Biotech Company 2017 Investor Presentation

2017 investor presentation covering clinical development programs across ALS, SMA/COPD, and heart failure indications. Includes forward-looking statements regarding R&D milestones, clinical trial timelines, and commercial potential of drug candidates focused on muscle function and contractility.